High-Dose Intramuscular Triamcinolone in Severe, Chronic, Life-Threatening Asthma

THE majority of patients with asthma have mild symptoms that can be controlled with beta-2 agonists, cromolyn, theophylline, inhaled corticosteroids, or a combination of these agents. Systemic corticosteroids are often required during acute exacerbations. A small percentage of patients, however, hav...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 324; no. 9; pp. 585 - 589
Main Authors: Ogirala, Raja G, Aldrich, Thomas K, Prezant, David J, Sinnett, Mark J, Enden, Jay B, Williams, M. Henry
Format: Journal Article
Language:English
Published: Boston, MA Massachusetts Medical Society 28-02-1991
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:THE majority of patients with asthma have mild symptoms that can be controlled with beta-2 agonists, cromolyn, theophylline, inhaled corticosteroids, or a combination of these agents. Systemic corticosteroids are often required during acute exacerbations. A small percentage of patients, however, have severe and even life-threatening asthma. This group is characterized by long-term dependency on steroids, frequent emergency room visits, recurrent hospitalizations, and often a history of requiring mechanical ventilation. Despite treatment with systemic steroids, these patients are forced to modify their lifestyle to adapt to their chronic, disabling shortness of breath. Methotrexate, 1 , 2 gold, 3 , 4 troleandomycin, 5 , 6 and a moderate monthly dose . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJM199102283240903